AlphaGrep UK Ltd Purchases 2,174 Shares of Cigna Group $CI

AlphaGrep UK Ltd raised its position in Cigna Group (NYSE:CI – Free Report) by 147.0% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 3,653 shares of the health services provider’s stock after acquiring an additional 2,174 shares during the period. AlphaGrep UK Ltd’s holdings in Cigna Group were worth $993,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. GQG Partners LLC bought a new stake in Cigna Group in the second quarter valued at approximately $1,628,918,000. Bank of America Corp DE bought a new stake in Cigna Group during the second quarter worth $827,692,000. Legal & General Group Plc bought a new position in Cigna Group in the 2nd quarter valued at approximately $542,779,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Cigna Group during the 2nd quarter valued at $241,312,000. Finally, Aberdeen Group plc raised its stake in shares of Cigna Group by 389.6% during the third quarter. Aberdeen Group plc now owns 1,078,857 shares of the health services provider’s stock valued at $283,907,000 after acquiring an additional 858,488 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Top Cigna Group Stories

Here are a few of the latest stories about CI:

  • Positive Sentiment: RBC maintained an Outperform rating and raised its price target to $346 from $337, citing Cigna’s third-quarter results and the developing 2027 outlook. RBC raises Cigna price target
  • Positive Sentiment: Cigna’s latest reported quarter beat estimates: adjusted earnings were $7.98 per share versus a $7.52 consensus, and revenue rose 5.6% year over year to $73.79 billion. Cigna Q3 beat and outlook
  • Neutral Sentiment: The Cigna Group Foundation announced $31.5 million in grants for community organizations across 10 states, supporting youth mental health, veterans, and people with complex health conditions. The announcement highlights community investment but provides no direct financial outlook update. Cigna Foundation grants

Cigna Group Price Performance

NYSE CI opened at $270.83 on Friday. Cigna Group has a 1-year low of $257.85 and a 1-year high of $318.05. The business’s fifty day moving average price is $288.03 and its 200-day moving average price is $282.99. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a market capitalization of $71.36 billion, a price-to-earnings ratio of 11.95, a PEG ratio of 1.01 and a beta of 0.25.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The business had revenue of $73.79 billion during the quarter, compared to the consensus estimate of $72.64 billion. During the same period in the previous year, the company posted $7.83 EPS. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. On average, equities analysts predict that Cigna Group will post 30.70 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be issued a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is currently 27.54%.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the topic of several research analyst reports. Piper Sandler cut their target price on Cigna Group from $370.00 to $360.00 and set an “overweight” rating on the stock in a research report on Thursday, November 12th. Jefferies Financial Group increased their price objective on Cigna Group from $288.00 to $304.00 and gave the stock a “hold” rating in a report on Thursday, November 12th. Guggenheim cut their target price on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating for the company in a research report on Friday, November 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $340.00 price target on shares of Cigna Group in a report on Friday, November 6th. Finally, Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $387.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, November 11th. Fourteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $337.35.

Check Out Our Latest Research Report on CI

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.